14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.52 $181.66 Wednesday, 28th Feb 2024 ALNY stock ended at $155.23. This is 2.37% less than the trading day before Tuesday, 27th Feb 2024. During the day the stock fluctuated 3.22% from a day low at $153.94 to a day high of $158.90.
90 days $143.52 $199.38
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2024-02-28 $156.56 $158.90 $153.94 $155.23 827 662
2024-02-27 $160.00 $161.31 $157.91 $159.00 612 777
2024-02-26 $156.49 $159.04 $153.94 $158.66 548 949
2024-02-23 $163.00 $163.01 $155.82 $157.65 1 197 664
2024-02-22 $154.47 $164.02 $154.22 $162.81 1 157 745
2024-02-21 $150.31 $155.38 $148.84 $154.74 3 546 302
2024-02-20 $146.98 $150.06 $146.11 $149.69 1 254 116
2024-02-16 $148.00 $150.93 $146.82 $147.00 1 883 389
2024-02-15 $150.00 $153.27 $143.52 $147.43 5 395 390
2024-02-14 $162.57 $164.63 $161.51 $164.15 842 370
2024-02-13 $164.89 $166.50 $160.84 $162.00 792 456
2024-02-12 $170.01 $171.55 $166.87 $169.34 782 410
2024-02-09 $169.49 $171.86 $168.54 $170.03 480 589
2024-02-08 $168.57 $170.25 $165.59 $169.50 882 012
2024-02-07 $172.55 $172.55 $167.43 $168.60 582 107
2024-02-06 $170.65 $173.18 $169.81 $172.18 1 430 391
2024-02-05 $172.17 $172.73 $168.00 $170.70 571 163
2024-02-02 $172.76 $174.48 $169.32 $173.06 628 061
2024-02-01 $173.54 $176.35 $172.21 $174.92 562 129
2024-01-31 $179.49 $179.80 $172.37 $172.91 810 946
2024-01-30 $180.45 $181.66 $178.36 $180.12 467 107
2024-01-29 $179.13 $181.50 $176.12 $180.96 1 021 352
2024-01-26 $183.88 $184.29 $179.47 $179.62 431 694
2024-01-25 $185.43 $188.69 $183.03 $183.93 518 615
2024-01-24 $190.72 $191.72 $185.13 $185.20 516 165
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT